聚-l/d-乳酸植入物 (RegJoint) 与关节插座治疗甲骨管炎症:随机对照临床试验的15年后续研究
Raine Tiihonen1, Thomas Hackenberg2, Eero Waris2,3
1Päijät-Häme Central Hospital, Lahti, Finland.
Hand (New York, N.Y.)
|August 31, 2025
概括
在炎症性关节炎中,RegJoint植入物和肌插入显示出类似的长期结果. 这两种方法都导致握力下降,RegJoint组报告了更多的疼痛.
科学领域:
- 骨科手术
- 关节病学
- 生物材料科学
背景情况:
- 类风湿性关节炎通常会导致形手腕关节 (TMC) 的破坏,传统上通过形手腕切除和肌插入进行治疗.
- 聚乳酸RegJoint植入物为TMC关节整形提供了潜在的替代方案,在类风湿性关节炎患者中显示出积极的短期结果.
研究的目的:
- 在患有炎症性关节炎的患者中,评估RegJoint植入物的长期疗效和结果与肌插入相比.
主要方法:
- 一项随机对照试验比较了部分梯形切除术与RegJoint植入物与TMC关节整形手术的肌插座.
- 该研究包括患有血清阳性类风湿性关节炎,青少年类风湿性关节炎和其他类型的炎症性关节炎的患者.
- 在使用RegJoint植入器的13名患者和使用肌插入器的8名患者中,长期随访平均为14. 9年.
主要成果:
- 在最终随访时,RegJoint和肌插入组之间没有观察到疼痛,功能,强度或整体功能能力的显著差异.
- 这两组手术患者的握力从手术前的水平显著下降,并在2年后的水平显著下降.
- 与手术前评估相比,接受RegJoint植入物的患者在最后的随访中报告疼痛增加.
结论:
- 在患有炎症性关节炎的患者中,RegJoint植入物和肌插入都提供了可比的长期结果.
- 尽管功能结果相似,但在长期内,两组的握力都下降了.
- 需要进一步的研究来验证这些发现在更大的患者群体中,并探索潜在的长期并发症或益处.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...